PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
Pharmacogenomics
; 21(11): 797-807, 2020 07.
Article
em En
| MEDLINE
| ID: mdl-32635813
ABSTRACT
The incorporation of personalized medicine interventions into routine healthcare constitutes an opportunity to improve patients' quality of life, as it empowers implementation of innovative, individualized clinical interventions that maximize efficacy and/or minimize the risk of adverse drug reactions. In order to ensure equal access to genomic testing for all patients, the costs associated with these interventions must be reimbursed by payers and insurance bodies. As such, it is of utmost importance to thoroughly evaluate these interventions both in terms of their clinical effectiveness and their economic cost. This article discusses the impact of personalized medicine interventions in terms of both health outcomes and value, which directly impacts on their pricing and reimbursement by the various national healthcare systems.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Farmacogenética
/
Avaliação de Resultados em Cuidados de Saúde
/
Medicina de Precisão
/
Assistência ao Paciente
/
Reembolso de Seguro de Saúde
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article